中低收入国家高血压指南选择对需降压药物治疗成人比例的影响:50国1 037 215人的横断面研究
该研究基于50个中低收入国家具有全国代表性的调查数据,纳入30至70岁成人1 037 215人,比较4种高血压指南下需接受降压药物治疗的成人比例。结果显示,不同指南下该比例差异显著,美国心脏病学会/美国心脏协会指南下最高,世界卫生组织指南下最低,且不知晓自己患有高血压者是差异的主要贡献者。
要点
- 不同高血压指南下需降压治疗的比例差异大,ACC/AHA最高,WHO最低。
- 不知晓自身高血压状态是导致指南间治疗需求比例差异的主要因素。
- 65-69岁年龄组中不同指南间的治疗需求比例差异最大。
核心结论
- 不同高血压指南的选择会导致中低收入国家需接受降压药物治疗的成人比例出现显著差异。
- 政策制定者在扩大高血压照护规模时需谨慎考虑采用何种指南,因其对卫生系统能力影响重大。
研究设计与样本
- 横断面研究,提取50个中低收入国家具有全国代表性调查中30至70岁成人的年龄、性别、血压、治疗与诊断状态、吸烟及体重指数数据,共纳入1 037 215人。
主要发现
- 需降压药物治疗的成人比例在ACC/AHA指南下最高:女性27.7%(95%CI 27.2-28.2),男性35.0%(95%CI 34.4-35.7)。
- 140/90 mm Hg阈值下:女性26.1%(95%CI 25.5-26.6),男性31.2%(95%CI 30.6-31.9)。
- NICE指南下:女性11.8%(95%CI 11.4-12.1),男性15.7%(95%CI 15.3-16.2);WHO指南下:女性9.2%(95%CI 8.9-9.5),男性11.0%(95%CI 10.6-11.4)。
- 不知晓自己患有高血压者是不同指南标准下需治疗比例差异的主要贡献者。
- 差异在65-69岁年龄组最大:ACC/AHA下女性60.2%(95%CI 58.8-61.6)、男性70.1%(95%CI 68.8-71.3);WHO下女性20.1%(95%CI 18.8-21.3)、男性24.1%(95%CI 22.3-25.9)。
关键数值与推荐
- 比较的4种指南为:2017年美国心脏病学会/美国心脏协会指南、常用140/90 mm Hg阈值、2016年世界卫生组织HEARTS指南、2019年英国国家卫生与临床优化研究所指南。
临床怎么用
- 临床医生应知晓不同指南下需降压治疗的人群范围差异显著,尤其在老年人群中。
- 在资源有限的中低收入国家,选择高血压指南时需权衡治疗需求与卫生系统承载能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current hypertension guidelines vary substantially in their definition of who should be offered blood pressure-lowering medications. Understanding the effect of guideline choice on the proportion of adults who require treatment is crucial for planning and scaling up hypertension care in low- and middle-income countries. METHODS: We extracted cross-sectional data on age, sex, blood pressure, hypertension treatment and diagnosis status, smoking, and body mass index for adults 30 to 70 years of age from nationally representative surveys in 50 low- and middle-income countries (N = 1 037 215). We aimed to determine the effect of hypertension guideline choice on the proportion of adults in need of blood pressure-lowering medications. We considered 4 hypertension guidelines: the 2017 American College of Cardiology/American Heart Association guideline, the commonly used 140/90 mm Hg threshold, the 2016 World Health Organization HEARTS guideline, and the 2019 UK National Institute for Health and Care Excellence guideline. RESULTS: The proportion of adults in need of blood pressure-lowering medications was highest under the American College of Cardiology/American Heart Association, followed by the 140/90 mm Hg, National Institute for Health and Care Excellence, and World Health Organization guidelines (American College of Cardiology/American Heart Association: women, 27.7% [95% CI, 27.2-28.2], men, 35.0% [95% CI, 34.4-35.7]; 140/90 mm Hg: women, 26.1% [95% CI, 25.5-26.6], men, 31.2% [95% CI, 30.6-31.9]; National Institute for Health and Care Excellence: women, 11.8% [95% CI, 11.4-12.1], men, 15.7% [95% CI, 15.3-16.2]; World Health Organization: women, 9.2% [95% CI, 8.9-9.5], men, 11.0% [95% CI, 10.6-11.4]). Individuals who were unaware that they have hypertension were the primary contributor to differences in the proportion needing treatment under different guideline criteria. Differences in the proportion needing blood pressure-lowering medications were largest in the oldest (65-69 years) age group (American College of Cardiology/American Heart Association: women, 60.2% [95% CI, 58.8-61.6], men, 70.1% [95% CI, 68.8-71.3]; World Health Organization: women, 20.1% [95% CI, 18.8-21.3], men, 24.1.0% [95% CI, 22.3-25.9]). For both women and men and across all guidelines, countries in the European and Eastern Mediterranean regions had the highest proportion of adults in need of blood pressure-lowering medicines, whereas the South and Central Americas had the lowest. CONCLUSIONS: There was substantial variation in the proportion of adults in need of blood pressure-lowering medications depending on which hypertension guideline was used. Given the great implications of this choice for health system capacity, policy makers will need to carefully consider which guideline they should adopt when scaling up hypertension care in their country.
引用
- Sudharsanan N, Theilmann M, Kirschbaum TK, et al. Variation in the Proportion of Adults in Need of Blood Pressure-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries: A Cross-Sectional Study of 1 037 215 Individuals From 50 Nationally Representative Surveys. Circulation. 2021. PMID: 33554610. doi:10.1161/CIRCULATIONAHA.120.051620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。